Northern Light Venture Capital
NLVC is a San Francisco Bay Area–based venture firm, founded in 2005, that invests at the intersection of enterprise, healthcare, and consumer opportunities. The firm emphasizes early-stage technology investing and supports founders with capital plus operational, technical, and strategic expertise drawn from experienced entrepreneurs, scientists, and engineers.
Northern Light Venture Capital
Services
Capital / Early-stage investment
Provides funding focused on early-stage technology opportunities.
Strategic guidance and mentorship
Ongoing advisory and mentorship from founders, operating executives, and market experts to help shape product, go-to-market, and company strategy.
Operational and technical expertise
Provides operational and technical insights based on first-hand experience building companies and engineering products.
Network and introductions
Access to NLVC’s professional network, connections, and resources across technology and healthcare industries.
Investment vetting and risk review
Thorough vetting of risks and opportunities for prospective investments, balancing foresight on secular trends with return objectives.
Capital / Early-stage investment
Provides funding focused on early-stage technology opportunities.
Strategic guidance and mentorship
Ongoing advisory and mentorship from founders, operating executives, and market experts to help shape product, go-to-market, and company strategy.
Operational and technical expertise
Provides operational and technical insights based on first-hand experience building companies and engineering products.
Network and introductions
Access to NLVC’s professional network, connections, and resources across technology and healthcare industries.
Investment vetting and risk review
Thorough vetting of risks and opportunities for prospective investments, balancing foresight on secular trends with return objectives.
Portfolio
Develops cell and sample processing products for cell separation.
#Biotechnology / Cell processing
Provider of high-resolution, high-content, high-sensitivity cell analysis solutions using Full Spectrum Profiling™ technology.
#Life sciences / Cell analysis
Founded in 2015 to develop AI and deep learning systems for self-driving vehicles; later became a subsidiary of Apple Inc.
#Autonomous systems / Artificial intelligence
Software platform for founders, investors, and employees to manage equity and ownership.
#Financial software / Equity management
Clinical-stage cancer immunotherapy company developing myeloid checkpoint inhibitors.
#Biotechnology / Oncology
Develops cell and sample processing products for cell separation.
#Biotechnology / Cell processing
Provider of high-resolution, high-content, high-sensitivity cell analysis solutions using Full Spectrum Profiling™ technology.
#Life sciences / Cell analysis
Founded in 2015 to develop AI and deep learning systems for self-driving vehicles; later became a subsidiary of Apple Inc.
#Autonomous systems / Artificial intelligence
Software platform for founders, investors, and employees to manage equity and ownership.
#Financial software / Equity management
Clinical-stage cancer immunotherapy company developing myeloid checkpoint inhibitors.
#Biotechnology / Oncology